Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q2 2017 · 10-Q
Revenue$112.00K$112.00K−22.2% vs Q2 2016 Net Income-$2.95M-$2.95MN/M vs Q2 2016 EPS Diluted-$0.08-$0.08N/M vs Q2 2016 Operating Income-$2,968,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$2,127,000— Margins · derivedOperating margin-2650.0%−1693.1 pt vs Q2 2016
Net margin-2629.5%−1255.9 pt vs Q2 2016
ended Jun 30, 2017 · filed Aug 14, 2017 · 45 d after period end